Clinical Trials Directory

Trials / Unknown

UnknownNCT06560086

Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2

Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Testicular Macrophage Trem2

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Affiliated Hospital of Nantong University · Academic / Other
Sex
Male
Age
8 Weeks – 13 Weeks
Healthy volunteers
Accepted

Summary

Reduced hormone insulin-like 3, exclusively secreted by Leydig cells, has been identified as the recognized mechanism for cryptorchidism. Testicular macrophages residing in the testicular interstitium were thought to play a vital role in maintaining hormone secretion of Leydig cells. However, the contribution of macrophages to cryptorchidism remained poorly understood. Here, after 14 days of ketoconazole treatment, levels of both Trem2 and insulin-like 3 significantly decrease in human embryonic testes compared to the untreated control group. Conversely, 14 days of luteinizing hormone stimulation lead to elevated levels of Trem2 and insulin-like 3 in the testes compared to the untreated control group. Additionally, researchers find a positive correlation between Trem2 and insulin-like 3 expression in a human ex vivo tissue culture model. In summary, the study will propose Trem2 as a novel target for maintaining normal testicular descent by regulating the testicular immune microenvironment.

Conditions

Interventions

TypeNameDescription
DRUGKetoconazoleA fetal developmental stage is precisely determined. Then, fetal tissues are extracted for in vitro cultivation. Intact aborted fetal testicular tissues are cultured in a medium containing 10-6 mol/L ketoconazole, which is the injectable solution powder. Ketoconazole is administered starting on the first day and then every other day, for a total of 7 times over the 14-day in vitro culture period.
DRUGLuteinizing HormoneA fetal developmental stage is precisely determined. Then, fetal tissues are extracted for in vitro cultivation. Intact aborted fetal testicular tissues are cultured in a medium containing 1 IU/mL luteinizing hormone, which is the injectable solution powder. Luteinizing hormone is administered starting on the first day and then every other day, for a total of 7 times over the 14-day in vitro culture period.

Timeline

Start date
2024-02-03
Primary completion
2024-12-01
Completion
2024-12-31
First posted
2024-08-19
Last updated
2024-08-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06560086. Inclusion in this directory is not an endorsement.